Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas

Clinical trial NCT02973672 · COMPLETED

Trial details

NCT number: NCT02973672
Sponsor: Surgimab
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colon Cancer Rectum Cancer Pancreas Cancer Metastatic Colorectal Cancer Recurrent Colorectal Carcinoma

Start date: 2016-01-01
Primary completion: 2019-04-15
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.